Monness, Crespi, Hardt Upgrades Coventry Health Care to Neutral (CVH)

By admin | 6 years ago

Coventry Health Care (NYSE: CVH) was upgraded by research analysts at Monness, Crespi, Hardt from a “sell” rating to a “neutral” rating in a report released on Monday.

Shares of Coventry Health Care traded up 0.10% during mid-day trading on Monday, hitting $30.49. Coventry Health Care has a 52 week low of $25.78 and a 52 week high of $37.86. The company has a market cap of $4.356 billion and a P/E ratio of 7.32.

Coventry Health Care last announced its earnings results on Friday, April 27th. The company reported $0.62 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.66 by $0.04. The company’s quarterly revenue was up 11.1% on a year-over-year basis. On average, analysts predict that Coventry Health Care will post $0.74 earnings per share next quarter.

A number of other analysts have also recently weighed in on CVH. Analysts at Zacks reiterated a “neutral” rating on shares of Coventry Health Care in a research note to investors on Monday, April 30th. They now have a $32.00 price target on the stock. Separately, analysts at Bank of America (NYSE: BAC) cut their price target on shares of Coventry Health Care from $39.00 to $38.00 in a research note to investors on Monday, April 30th. Finally, analysts at Wedbush raised their price target on shares of Coventry Health Care from $34.00 to $36.00 in a research note to investors on Monday, April 9th.

Coventry Health Care, Inc. is a diversified national managed healthcare company based in Bethesda, Maryland, operating health plans, insurance companies, network rental and workers’ compensation services companies.

About the author